Brazil approves proposal to import Bharat Biotech's Covaxin with regulations

New Delhi, June 05 (ANI): Brazil has approved the import of Bharat Biotech manufactured COVID vaccine Covaxin into the country with regulations, informed ANVISA on Friday. But the approval came with strict conditions which limits the number of doses that can be imported and with restrictions on the use of vaccines in Brazil. The authorization defined an amount of four million doses. The health surveillance agency had earlier denied permission to import Covaxin. After using the authorised doses, the agency will analyse the data for the monitoring the use of the vaccine in order to assess the next quantities to be imported.